LEXARIA BIOSCIENCE CORP. Operating Lease, Right-of-Use Asset, Amortization Expense
LEXARIA BIOSCIENCE CORP. (LEXX) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $22.40 thousand for the 9-month period ending 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-07-13
- LEXARIA BIOSCIENCE CORP. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-05-31 was $7.60K.
- LEXARIA BIOSCIENCE CORP. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-02-28 was $7.47K.
- LEXARIA BIOSCIENCE CORP. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-11-30 was $7.33K.
- LEXARIA BIOSCIENCE CORP. operating lease, right-of-use asset, amortization expense for the quarter ending 2020-11-30 was -$8.73K.
- LEXARIA BIOSCIENCE CORP. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $32.60K.
- LEXARIA BIOSCIENCE CORP. operating lease, right-of-use asset, amortization expense for fiscal 2020 was -$33.37K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-05-31 | $7.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-07-13 | $15.07K derived: sum of 2 quarters · filed 2026-07-13 | $22.40K 10-Q · filed 2026-07-13 | |
| 2026-02-28 | $7.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-04-13 | $14.80K 10-Q · filed 2026-04-13 | ||
| 2025-11-30 | $7.33K 10-Q · filed 2026-01-13 | |||
| 2025-08-31 | $28.03K 10-Q · filed 2026-07-13 | |||
| 2024-08-31 | $32.60K 10-K · filed 2025-11-28 | |||
| 2021-05-31 | $9.05K 10-Q · filed 2021-07-15 | |||
| 2020-11-30 | -$8.73K 10-Q · filed 2021-01-14 | |||
| 2020-08-31 | -$33.37K 10-K · filed 2020-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |